By Professor Glenda Halliday

Journal articles

Marian OC; Teo JD; Lee JY; Song H; Kwok JB; Landin-Romero R; Halliday G; Don AS, 2023, 'Disrupted myelin lipid metabolism differentiates frontotemporal dementia caused by GRN and C9orf72 gene mutations', Acta Neuropathologica Communications, 11, http://dx.doi.org/10.1186/s40478-023-01544-7

Lok HC; Katzeff JS; Hodges JR; Piguet O; Fu YH; Halliday GM; Kim WS, 2023, 'Elevated GRO-α and IL-18 in serum and brain implicate the NLRP3 inflammasome in frontotemporal dementia', Scientific Reports, 13, http://dx.doi.org/10.1038/s41598-023-35945-4

Youssef P; Hughes L; Kim WS; Halliday GM; Lewis SJG; Cooper A; Dzamko N, 2023, 'Evaluation of plasma levels of NFL, GFAP, UCHL1 and tau as Parkinson's disease biomarkers using multiplexed single molecule counting', Scientific Reports, 13, http://dx.doi.org/10.1038/s41598-023-32480-0

Pavan C; Jin J; Jong S; Strbenac D; Davis RL; Sue CM; Johnston J; Lynch T; Halliday G; Kirik D; Parish CL; Thompson LH; Ovchinnikov DA, 2023, 'Generation of the iPSC line FINi002-A from a male Parkinson's disease patient carrying compound heterozygous mutations in the PRKN gene', Stem Cell Research, 73, http://dx.doi.org/10.1016/j.scr.2023.103211

Tan RH; McCann H; Shepherd CE; Pinkerton M; Mazumder S; Devenney EM; Adler GL; Rowe DB; Kril J; Halliday GM; Kiernan MC, 2023, 'Heterogeneity of cortical pTDP-43 inclusion morphologies in amyotrophic lateral sclerosis', Acta Neuropathologica Communications, 11, http://dx.doi.org/10.1186/s40478-023-01670-2

Chatterton Z; Lamichhane P; Ahmadi Rastegar D; Fitzpatrick L; Lebhar H; Marquis C; Halliday G; Kwok JB, 2023, 'Single-cell DNA methylation sequencing by combinatorial indexing and enzymatic DNA methylation conversion', Cell and Bioscience, 13, http://dx.doi.org/10.1186/s13578-022-00938-9

Kiernan MC; Halliday GM; Rowe DB; Tan RH, 2023, 'The importance of patient-centred drug development for amyotrophic lateral sclerosis', Neuropathology and Applied Neurobiology, 49, http://dx.doi.org/10.1111/nan.12944

Shepherd CE; Lewis SJG; Tisch S; Mccann H; Jonker B; Halliday GM, 2023, 'Effects of STN/SNr deep brain stimulation in a case of progressive supranuclear palsy with a Parkinson disease phenotype', Journal of Neuropathology and Experimental Neurology, 82, pp. 821 - 823, http://dx.doi.org/10.1093/jnen/nlad052

Pinkerton M; Lourenco G; Pacheco MT; Halliday GM; Kiernan MC; Tan RH, 2023, 'Survival in sporadic ALS is associated with lower p62 burden in the spinal cord', Journal of Neuropathology and Experimental Neurology, 82, pp. 769 - 773, http://dx.doi.org/10.1093/jnen/nlad051

Qi R; Sammler E; Gonzalez-Hunt CP; Barraza I; Pena N; Rouanet JP; Naaldijk Y; Goodson S; Fuzzati M; Blandini F; Erickson KI; Weinstein AM; Lutz MW; Kwok JB; Halliday GM; Dzamko N; Padmanabhan S; Alcalay RN; Waters C; Hogarth P; Simuni T; Smith D; Marras C; Tonelli F; Alessi DR; West AB; Shiva S; Hilfiker S; Sanders LH, 2023, 'A blood-based marker of mitochondrial DNA damage in Parkinson's disease', Science Translational Medicine, 15, http://dx.doi.org/10.1126/SCITRANSLMED.ABO1557

Affleck AJ; Sachdev PS; Halliday GM, 2023, 'Past antihypertensive medication use is associated with lower levels of small vessel disease and lower Aβ plaque stage in the brains of older individuals', Neuropathology and Applied Neurobiology, 49, pp. e12922, http://dx.doi.org/10.1111/nan.12922

Yang Y; Rowe D; McCann H; Shepherd CE; Kril JJ; Kiernan MC; Halliday GM; Tan RH, 2023, 'Treatment with the copper compound CuATSM has no significant effect on motor neuronal pathology in patients with ALS', Neuropathology and Applied Neurobiology, 49, http://dx.doi.org/10.1111/nan.12919

Henden L; Fearnley LG; Grima N; McCann EP; Dobson-Stone C; Fitzpatrick L; Friend K; Hobson L; Moi Fat SC; Rowe DB; D Silva S; Kwok JB; Halliday GM; Kiernan MC; Mazumder S; Timmins HC; Zoing M; Pamphlett R; Adams L; Bahlo M; Blair IP; Williams KL, 2023, 'Short tandem repeat expansions in sporadic amyotrophic lateral sclerosis and frontotemporal dementia', Science Advances, 9, http://dx.doi.org/10.1126/sciadv.ade2044

Ge YJ; Ou YN; Deng YT; Wu BS; Yang L; Zhang YR; Chen SD; Huang YY; Dong Q; Tan L; Yu JT; Ferrari R; Hernandez DG; Nalls MA; Rohrer JD; Ramasamy A; Kwok JBJ; Dobson-Stone C; Brooks WS; Schofield PR; Halliday GM; Hodges JR; Piguet O; Bartley L; Thompson E; Haan E; Hernández I; Ruiz A; Boada M; Borroni B; Padovani A; Cruchaga C; Cairns NJ; Benussi L; Binetti G; Ghidoni R; Forloni G; Galimberti D; Fenoglio C; Serpente M; Scarpini E; Clarimón J; Lleó A; Blesa R; Waldö ML; Nilsson K; Nilsson C; Mackenzie IRA; Hsiung GYR; Mann DMA; Grafman J; Morris CM; Attems J; Griffiths TD; McKeith IG; Thomas AJ; Pietrini P; Huey ED; Wassermann EM; Baborie A; Jaros E; Tierney MC; Pastor P; Razquin C; Ortega-Cubero S; Alonso E; Perneczky R; Diehl-Schmid J; Alexopoulos P; Kurz A; Rainero I; Rubino E; Pinessi L; Rogaeva E; St. George-Hyslop P; Rossi G; Tagliavini F; Giaccone G; Rowe JB; Schlachetzki JCM; Uphill J; Collinge J; Mead S; Danek A; Van Deerlin VM; Grossman M; Trojanowski JQ; van der Zee J; Deschamps W; Van Langenhove T; Cruts M; Van Broeckhoven C; Cappa SF; Le Ber I; Hannequin D; Golfier V; Vercelletto M; Brice A; Nacmias B; Sorbi S, 2023, 'Prioritization of Drug Targets for Neurodegenerative Diseases by Integrating Genetic and Proteomic Data From Brain and Blood', Biological Psychiatry, 93, pp. 770 - 779, http://dx.doi.org/10.1016/j.biopsych.2022.11.002

Forrest SL; Kim JH; Crockford DR; Huynh K; Cheong R; Knott S; Kane MA; Ittner LM; Halliday GM; Kril JJ, 2023, 'Distribution Patterns of Astrocyte Populations in the Human Cortex', Neurochemical Research, 48, pp. 1222 - 1232, http://dx.doi.org/10.1007/s11064-022-03700-2

Mazumder S; Mccann H; D'silva S; Furlong S; Shepherd CE; Kril JJ; Halliday GM; Rowe DB; Kiernan MC; Tan RH, 2023, 'Riluzole is associated with decreasing neuritic plaque severity in amyotrophic lateral sclerosis', Brain, 146, pp. E17 - E19, http://dx.doi.org/10.1093/brain/awac467

Hsiao JHT; Tanglay O; Li AA; Strobbe AYG; Kim WS; Halliday GM; Fu YH, 2023, 'Role of Oligodendrocyte Lineage Cells in Multiple System Atrophy', Cells, 12, http://dx.doi.org/10.3390/cells12050739

Nelson PT; Lee EB; Cykowski MD; Alafuzoff I; Arfanakis K; Attems J; Brayne C; Corrada MM; Dugger BN; Flanagan ME; Ghetti B; Grinberg LT; Grossman M; Grothe MJ; Halliday GM; Hasegawa M; Hokkanen SRK; Hunter S; Jellinger K; Kawas CH; Keene CD; Kouri N; Kovacs GG; Leverenz JB; Latimer CS; Mackenzie IR; Mao Q; McAleese KE; Merrick R; Montine TJ; Murray ME; Myllykangas L; Nag S; Neltner JH; Newell KL; Rissman RA; Saito Y; Sajjadi SA; Schwetye KE; Teich AF; Thal DR; Tomé SO; Troncoso JC; Wang SHJ; White CL; Wisniewski T; Yang HS; Schneider JA; Dickson DW; Neumann M, 2023, 'LATE-NC staging in routine neuropathologic diagnosis: an update', Acta Neuropathologica, 145, pp. 159 - 173, http://dx.doi.org/10.1007/s00401-022-02524-2

Fu YH; Zhou L; Li H; Hsiao J; Li B; Tanglay O; Auwyang AD; Wang E; Feng J; Kim WS; Liu J; Halliday GM, 2023, 'Correction to: Adaptive structural changes in the motor cortex and white matter in Parkinson’s disease (Acta Neuropathologica, (2022), 144, 5, (861-879), 10.1007/s00401-022-02488-3)', Acta Neuropathologica, 145, pp. 157, http://dx.doi.org/10.1007/s00401-022-02523-3

Tse NY; Bocchetta M; Todd EG; Devenney EM; Tu S; Caga J; Hodges JR; Halliday GM; Irish M; Kiernan MC; Piguet O; Rohrer JD; Ahmed RM, 2023, 'Distinct hypothalamic involvement in the amyotrophic lateral sclerosis-frontotemporal dementia spectrum', Neuroimage Clinical, 37, http://dx.doi.org/10.1016/j.nicl.2022.103281

Labrador-Garrido A; Zhong S; Hughes L; Keshiya S; Kim WS; Halliday GM; Dzamko N, 2023, 'Live cell in situ lysosomal GCase activity correlates to alpha-synuclein levels in human differentiated neurons with LRRK2 and GBA1 mutations', Frontiers in Cellular Neuroscience, 17, http://dx.doi.org/10.3389/fncel.2023.1229213

Phan K; He Y; Bhatia S; Pickford R; Mcdonald G; Mazumder S; Timmins HC; Hodges JR; Piguet O; Dzamko N; Halliday GM; Kiernan MC; Kim WS, 2023, 'Multiple pathways of lipid dysregulation in amyotrophic lateral sclerosis', Brain Communications, 5, http://dx.doi.org/10.1093/braincomms/fcac340

Hwang YT; Halliday GM; Piguet O; Burrell JR, 2023, 'Assessing utility of imaging based biomarker to differentiate pathologically classified frontotemporal lobar degeneration syndromes', Alzheimer's & Dementia, 19, http://dx.doi.org/10.1002/alz.075559

McCann H; Halliday GM; Shepherd CE, 2023, 'The relationship between traumatic brain injury and the neuropathology of dementia', Alzheimer's & Dementia, 19, http://dx.doi.org/10.1002/alz.061668

Fumagalli GG; Sorrentino F; de Boer SCM; Riedl L; Landin‐Romero R; Matis S; Southwood D; Chatterton Z; Diehl‐Schmid J; Halliday GM; Ducharme S; Piguet O; Pijnenburg YAL; Galimberti D, 2023, 'Visual rating scales of atrophy to differentiate Frontotemporal dementia from Primary psychiatric disorder: results from DIPPA study', Alzheimer's & Dementia, 19, http://dx.doi.org/10.1002/alz.073286

Fumagalli GG; Sorrentino F; de Boer SCM; Riedl L; Landin‐Romero R; Matis S; Southwood D; Chatterton Z; Diehl‐Schmid J; Halliday GM; Ducharme S; Piguet O; Pijnenburg YAL; Galimberti D, 2023, 'Visual rating scales of atrophy to differentiate Frontotemporal dementia from Primary psychiatric disorder: results from DIPPA study', Alzheimer's & Dementia, 19, http://dx.doi.org/10.1002/alz.081607

Matar E; Ehgoetz Martens KA; Phillips JR; Wainstein G; Halliday GM; Lewis SJG; Shine JM, 2022, 'Dynamic network impairments underlie cognitive fluctuations in Lewy body dementia', Npj Parkinson S Disease, 8, http://dx.doi.org/10.1038/s41531-022-00279-x

Ahmadi Rastegar D; Hughes LP; Perera G; Keshiya S; Zhong S; Gao J; Halliday GM; Schüle B; Dzamko N, 2022, 'Effect of LRRK2 protein and activity on stimulated cytokines in human monocytes and macrophages', Npj Parkinson S Disease, 8, http://dx.doi.org/10.1038/s41531-022-00297-9

Phillips JR; Matar E; Ehgoetz Martens KA; Moustafa AA; Halliday GM; Lewis SJG, 2022, 'Exploring the Sensitivity of Prodromal Dementia with Lewy Bodies Research Criteria', Brain Sciences, 12, http://dx.doi.org/10.3390/brainsci12121594

Bitar M; Weissleder C; North HF; Clearwater MS; Zalucki O; Halliday GM; Webster MJ; Piper M; Weickert CS; Barry G, 2022, 'Identifying gene expression profiles associated with neurogenesis and inflammation in the human subependymal zone from development through aging', Scientific Reports, 12, http://dx.doi.org/10.1038/s41598-021-03976-4

Fu YH; He Y; Phan K; Bhatia S; Pickford R; Wu P; Dzamko N; Halliday GM; Kim WS, 2022, 'Increased unsaturated lipids underlie lipid peroxidation in synucleinopathy brain', Acta Neuropathologica Communications, 10, http://dx.doi.org/10.1186/s40478-022-01469-7

Poewe W; Stankovic I; Halliday G; Meissner WG; Wenning GK; Pellecchia MT; Seppi K; Palma JA; Kaufmann H, 2022, 'Multiple system atrophy', Nature Reviews Disease Primers, 8, http://dx.doi.org/10.1038/s41572-022-00382-6

Mazumder S; Kiernan MC; Halliday GM; Timmins HC; Mahoney CJ, 2022, 'The contribution of brain banks to knowledge discovery in amyotrophic lateral sclerosis: A systematic review', Neuropathology and Applied Neurobiology, 48, http://dx.doi.org/10.1111/nan.12845

Fu YH; Zhou L; Li H; Hsiao JHT; Li B; Tanglay O; Auwyang AD; Wang E; Feng J; Kim WS; Liu J; Halliday GM, 2022, 'Adaptive structural changes in the motor cortex and white matter in Parkinson’s disease', Acta Neuropathologica, 144, pp. 861 - 879, http://dx.doi.org/10.1007/s00401-022-02488-3

Katzeff JS; Lok HC; Bhatia S; Fu YH; Halliday GM; Kim WS, 2022, 'ATP-binding cassette transporter expression is widely dysregulated in frontotemporal dementia with TDP-43 inclusions', Frontiers in Molecular Neuroscience, 15, http://dx.doi.org/10.3389/fnmol.2022.1043127

Hopfner F; Tietz AK; Ruf VC; Ross OA; Koga S; Dickson D; Aguzzi A; Attems J; Beach T; Beller A; Cheshire WP; van Deerlin V; Desplats P; Deuschl G; Duyckaerts C; Ellinghaus D; Evsyukov V; Flanagan ME; Franke A; Frosch MP; Gearing M; Gelpi E; van Gerpen JA; Ghetti B; Glass JD; Grinberg LT; Halliday G; Helbig I; Höllerhage M; Huitinga I; Irwin DJ; Keene DC; Kovacs GG; Lee EB; Levin J; Martí MJ; Mackenzie I; McKeith I; Mclean C; Mollenhauer B; Neumann M; Newell KL; Pantelyat A; Pendziwiat M; Peters A; Molina Porcel L; Rabano A; Matěj R; Rajput A; Rajput A; Reimann R; Scott WK; Seeley W; Selvackadunco S; Simuni T; Stadelmann C; Svenningsson P; Thomas A; Trenkwalder C; Troakes C; Trojanowski JQ; Uitti RJ; White CL; Wszolek ZK; Xie T; Ximelis T; Yebenes J; Müller U; Schellenberg GD; Herms J; Kuhlenbäumer G; Höglinger G, 2022, 'Common Variants Near ZIC1 and ZIC4 in Autopsy-Confirmed Multiple System Atrophy', Movement Disorders, 37, pp. 2110 - 2121, http://dx.doi.org/10.1002/mds.29164

Galper J; Dean NJ; Pickford R; Lewis SJG; Halliday GM; Kim WS; Dzamko N, 2022, 'Lipid pathway dysfunction is prevalent in patients with Parkinson's disease', Brain, 145, pp. 3472 - 3487, http://dx.doi.org/10.1093/brain/awac176

Trist BG; Genoud S; Roudeau S; Rookyard A; Abdeen A; Cottam V; Hare DJ; White M; Altvater J; Fifita JA; Hogan A; Grima N; Blair IP; Kysenius K; Crouch PJ; Carmona A; Rufin Y; Claverol S; Van Malderen S; Falkenberg G; Paterson DJ; Smith B; Troakes C; Vance C; Shaw CE; Al-Sarraj S; Cordwell S; Halliday G; Ortega R; Double KL, 2022, 'Altered SOD1 maturation and post-translational modification in amyotrophic lateral sclerosis spinal cord', Brain, 145, pp. 3108 - 3130, http://dx.doi.org/10.1093/brain/awac165

Chedid J; Labrador-Garrido A; Zhong S; Gao J; Zhao Y; Perera G; Kim WS; Halliday GM; Dzamko N, 2022, 'A small molecule toll-like receptor antagonist rescues α-synuclein fibril pathology', Journal of Biological Chemistry, 298, http://dx.doi.org/10.1016/j.jbc.2022.102260

Johnson EG; Kuiper W; Ahmed RM; Halliday GM; Burrell JR; Hodges JR; Guastella AJ; Piguet O; Kumfor F, 2022, 'Plasma Oxytocin Is Not Associated with Social Cognition or Behavior in Frontotemporal Dementia and Alzheimer's Disease Syndromes', Dementia and Geriatric Cognitive Disorders, 51, pp. 241 - 248, http://dx.doi.org/10.1159/000525087

Tse NY; Tu S; Chen Y; Caga J; Dobson-Stone C; Kwok JB; Halliday GM; Ahmed RM; Hodges JR; Piguet O; Kiernan MC; Devenney EM, 2022, 'Schizotypal traits across the amyotrophic lateral sclerosis–frontotemporal dementia spectrum: pathomechanistic insights', Journal of Neurology, 269, pp. 4241 - 4252, http://dx.doi.org/10.1007/s00415-022-11049-3

Foxe D; Hu A; Cheung SC; Ahmed RM; Cordato NJ; Devenney E; Hwang YT; Halliday GM; Mueller N; Leyton CE; Hodges JR; Burrell JR; Irish M; Piguet O, 2022, 'Utility of the Addenbrooke's Cognitive Examination III online calculator to differentiate the primary progressive aphasia variants', BRAIN COMMUNICATIONS, 4, http://dx.doi.org/10.1093/braincomms/fcac161

Phillips JR; Matar E; Ehgoetz Martens KA; Moustafa AA; Halliday GM; Lewis SJG, 2022, 'An Adaptive Measure of Visuospatial Impairment in Dementia with Lewy Bodies', Movement Disorders Clinical Practice, 9, pp. 619 - 627, http://dx.doi.org/10.1002/mdc3.13488

Weiss F; Labrador-Garrido A; Dzamko N; Halliday G, 2022, 'Immune responses in the Parkinson's disease brain', Neurobiology of Disease, 168, http://dx.doi.org/10.1016/j.nbd.2022.105700

Wenning GK; Stankovic I; Vignatelli L; Fanciulli A; Calandra-Buonaura G; Seppi K; Palma JA; Meissner WG; Krismer F; Berg D; Cortelli P; Freeman R; Halliday G; Höglinger G; Lang A; Ling H; Litvan I; Low P; Miki Y; Panicker J; Pellecchia MT; Quinn N; Sakakibara R; Stamelou M; Tolosa E; Tsuji S; Warner T; Poewe W; Kaufmann H, 2022, 'The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy', Movement Disorders, 37, pp. 1131 - 1148, http://dx.doi.org/10.1002/mds.29005

Katzeff JS; Bright F; Phan K; Kril JJ; Ittner LM; Kassiou M; Hodges JR; Piguet O; Kiernan MC; Halliday GM; Kim WS, 2022, 'Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis', Brain, 145, pp. 1598 - 1609, http://dx.doi.org/10.1093/brain/awac077

Boel JA; de Bie RMA; Schmand BA; Dalrymple-Alford JC; Marras C; Adler CH; Goldman JG; Tröster AI; Burn DJ; Litvan I; Geurtsen GJ; Bernard B; Stebbins G; Filoteo JV; Weintraub D; Caviness JN; Belden C; Zabetian CP; Cholerton BA; Huang X; Eslinger PJ; Leverenz JB; Duff-Canning S; Farrer M; Anderson TJ; Myall DJ; Naismith SL; Lewis SJG; Halliday GM; Wu RM; Williams-Gray CH; Breen DP; Barker RA; Yarnall AJ; Klein M; Mollenhauer B; Trenkwalder C; Kulisevsky J; Pagonabarraga J; Gasca-Salas C; Rodriguez-Oroz MC; Junque C; Segura B; Barone P; Santangelo G; Cammisuli DM; Biundo R; Antonini A; Weis L; Pedersen KF; Alves G, 2022, 'Level I PD-MCI Using Global Cognitive Tests and the Risk for Parkinson's Disease Dementia', Movement Disorders Clinical Practice, 9, pp. 479 - 483, http://dx.doi.org/10.1002/mdc3.13451

Hooshmand K; Halliday GM; Pineda SS; Sutherland GT; Guennewig B, 2022, 'Overlap between Central and Peripheral Transcriptomes in Parkinson’s Disease but Not Alzheimer’s Disease', International Journal of Molecular Sciences, 23, http://dx.doi.org/10.3390/ijms23095200

Chen Y; Landin-Romero R; Kumfor F; Irish M; Dobson-Stone C; Kwok JB; Halliday GM; Hodges JR; Piguet O, 2022, 'Cerebellar integrity and contributions to cognition in C9orf72-mediated frontotemporal dementia', Cortex, 149, pp. 73 - 84, http://dx.doi.org/10.1016/j.cortex.2021.12.014

Matar E; Brooks D; Lewis SJG; Halliday GM, 2022, 'Limbic thalamus atrophy is associated with visual hallucinations in Lewy body disorders', Neurobiology of Aging, 112, pp. 122 - 128, http://dx.doi.org/10.1016/j.neurobiolaging.2022.01.001

Back to profile page